Results 51 to 60 of about 31,621 (232)

Use of Plasmapheresis in Nephrology Practice

open access: yes, 2015
Plasma exchange (plasmapheresis) is a treatment method based on separating the plasma, one of the 4 components, from whole blood removed from the body and giving the remaining part back to the circulation with replacement fluid.
Mustafa Yaprak   +8 more
core   +1 more source

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye   +33 more
wiley   +1 more source

Composite atherogenic indices reveal a superior lipid profile in a Chinese longevity population: a cross-sectional cohort study

open access: yesScientific Reports
Our previous work revealed differences in conventional lipid parameters between individuals from the Bama longevity hotspot and general population controls.
Jiaqi Zhang   +7 more
doaj   +1 more source

Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)

open access: yesPulmonology, 2021
Background In December 2019, pneumonia associated with a novel coronavirus (COVID-19) was reported in Wuhan, China. Acute respiratory distress syndrome (ARDS) is the most frequently observed complication in COVID-19 patients with high mortality rates ...
Seyed MohammadReza Hashemian   +14 more
doaj   +1 more source

Plasmapheresis in Acute Liver Failure

open access: yes, 1986
A series of 9 patients with acute hepatic failure and Grade IV hepatic coma received daily plasmapheresis until they recovered or death ensued. Of the nine, seven (77%) showed an improvement in coma grade and five (55%) survived to leave hospital ...
C.O. Record, J.G. Freeman, K. Matthewson
core   +1 more source

Effect of DFPP on Ferroptosis in Peripheral Blood CD14+ Monocytes of Hyperlipidemic Patients Involving the ACSL4/LPCAT3/ALOX5 Pathway

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Hyperlipidemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD). Although statins are the cornerstone of lipid‐lowering therapy, their use may be limited in some patients by adverse effects. This study evaluated the possible impact of non‐drug treatment using double‐filtration plasmapheresis (DFPP) on CD14+
Yun Cheng   +3 more
wiley   +1 more source

Plasmapheresis-Induced Hypercalcaemia [PDF]

open access: yes, 2013
Guillain-Barré syndrome (GBS) is an acute inflammatory polyradiculoneuropathy that can cause total motor paralysis in severe cases. Reports of hypercalcaemia in patients with GBS are rare.
Al-Yaaruby, Saif   +2 more
core  

Inebilizumab in AQP4‐Seropositive NMOSD: One‐Year Follow‐Up From a Multicenter, Real‐World Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Real‐world evidence on inebilizumab among neuromyelitis optica spectrum disorder (NMOSD) patients is lacking. This study assessed inebilizumab among Chinese patients with aquaporin 4 autoantibody (AQP4‐IgG)‐seropositive NMOSD in a real‐world setting.
Mengcui Gui   +10 more
wiley   +1 more source

Effect of Educational Program Regarding Plasmapheresis on Nurses’ Performance for Patients with Autoimmune Diseases [PDF]

open access: yesTanta Scientific Nursing Journal
Background: Plasmapheresis is an essential therapeutic procedure used in themanagement of autoimmune diseases. Aim: This study aimed to evaluate theeffect of educational program regarding plasmapheresis on nurses’ performancefor patients with autoimmune ...
Mohamed El Sayis   +3 more
doaj   +1 more source

Synergistic Activity of Venetoclax and Rituximab in Multiply Relapsed or Refractory Waldenström Macroglobulinaemia [PDF]

open access: yesEJHaem
ABSTRACT Introduction There are limited options for multiply relapsed/refractory (R/R) Waldenström Macroglobulinaemia (WM) post Bruton tyrosine kinase inhibitors (BTKi). The synergy of venetoclax and rituximab (Ven‐R) may improve the poor outcomes with venetoclax monotherapy.
Josiah A   +7 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy